City
Epaper

Signity Pharmaceuticals bags title of 'The Fastest Growing Pharmaceutical Company of Central India'

By ANI | Updated: January 7, 2022 18:25 IST

Signity Pharmaceuticals Pvt. Ltd., an upcoming super-specialty company, has been honoured with the title of "The Fastest Growing Pharmaceutical Company of Central India" at the International Business Leadership Awards 2021.

Open in App

Pvt. Ltd., an upcoming super-specialty company, has been honoured with the title of "The Fastest Growing Pharmaceutical Company of Central India" at the International Business Leadership Awards 2021.

The award ceremony was organized at Hotel Novotel, Goa on December 23, 2021 by Faggan Singh Kulaste- the Minister Rural Development and Minister of Steel, Government of India, Pandit Sunil Bharala- the Chairman/ Minister of State, Labour Welfare Council, Government of Uttar Pradesh and famous Bollywood Actress- Poonam Dhillon.

India's drugs and pharmaceuticals exports stood at US$ 24.44 billion in FY21 making it the 12th largest exporter of medical goods in the world. In this scenario, Signity Pharmaceuticals is striving to emerge as a leading exporter of nutraceutical products. They have already earned a big reputation in exporting high-quality nutraceutical products to Europe, America & South East Asian Markets. Now, they are looking forward to pushing their R&D efforts further to establish their authority in the global pharmaceutical market. They have also introduced the India's first-of-its-kind liver preparation. Signity has also applied for its patent.

On this occasion, company's director Shridhar Dhavle said, "It has been a great journey for us. We have started our journey with a vision of introducing innovative drug formulations as an aid to the country's healthcare system. Our unique nutraceutical formulations have already gained acknowledgment across the country. We express our deep gratitude to the medical fraternity and all our well-wishers for their wholehearted support and confidence in us which always inspired us to excel and grow during the last 11 years."

Under the leadership of Bhupendra Marliwar along with Shridhar Dhavle & Vishal Mulani, Signity is all ready to cater to the needs of the existing medical infrastructure with novel and world-class drug formulations. Signity Pharmaceuticals offer a myriad range of industry-leading products like anti-infectives, life-saving drugs, hepatoprotective drugs, immunomodulators, neurotropics, advanced pain management drugs, nutraceutical formulations and respiratory formulations to continuously revolutionize the sector.

This story is provided by TPT.will not be responsible in any way for the content of this article. (ANI/TPT)

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: goaindiaPvt. ltd.StateShridhar dhavle
Open in App

Related Stories

NationalGolden Power: Indian Women Now Hold 24,000 Tonnes of Gold, Outshining Global Investors

MumbaiMumbai Man Pursuing PhD in US Booked for Sexually Abusing Woman on False Promise of Marriage

LifestyleCreative Rangoli Designs for Dhanteras and Diwali 2025 to Welcome Goddess Lakshmi

MumbaiMumbai Crime: Woman Arrested for Stealing Gold, Diamond Jewellery Worth ₹10 Lakh After Intoxicating Businessman

CricketIND vs PAK 2025 Live Streaming: Head-to-Head Record, When and Where to Watch India vs Pakistan Asia Cup Final

Business Realted Stories

BusinessEngineering excellence, tech talents an opportunity for Europe, "I'm very bullish on India," says Airbus's Rene Obermann

BusinessPiyush Goyal holds discussion with top EU leader to speed up trade talks

BusinessLIC raises stakes in Tata Consumer Products and Dabur India

BusinessIndia eyes bigger share in global rice market, BIRC 2025 to drive export push: IREF's Prem Garg

Business‘Modi Mission’: Berjis Desai’s book chronicles PM Modi’s journey from Vadnagar to global leadership